These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 19670421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C.
    Oliveira BR, Magalhães O, Furlanetto TW, Bertoluci MC.
    Diabetes Res Clin Pract; 2008 Feb; 79(2):e11-2. PubMed ID: 17904241
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C.
    Iwasa M, Mifuji-Moroka R, Hara N, Ishidome M, Iwata K, Sugimoto R, Tanaka H, Fujita N, Kobayashi Y, Takei Y.
    Diabetes Res Clin Pract; 2011 Dec; 94(3):468-70. PubMed ID: 22014765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.
    Heish MY, Dai CY, Huang JF, Lee LP, Hou NJ, Chuang WL, Yu ML.
    Am J Gastroenterol; 2008 Feb; 103(2):487-8; author reply 488. PubMed ID: 18289212
    [No Abstract] [Full Text] [Related]

  • 13. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F, Clément S.
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [Abstract] [Full Text] [Related]

  • 14. Comment on: Reyna et al. (2008) Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57:2595-2602.
    Shapiro H, Singer P, Attal-Singer J.
    Diabetes; 2009 Apr; 58(4):e5; author reply e6-7. PubMed ID: 19336685
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis: response to Lecube et al.
    Gentilucci UV, Picardi A, Pozzilli P.
    Diabetes Care; 2006 Nov; 29(11):2558-9; author reply 2559-60. PubMed ID: 17065704
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. HIV/hepatitis C co-infection and hepatic fibrosis: looking beyond HIV-associated immune suppression; the contribution of hepatic steatosis and insulin resistance.
    Bhagani S.
    Gut; 2009 Dec; 58(12):1579-81. PubMed ID: 19923343
    [No Abstract] [Full Text] [Related]

  • 19. Epidemiology of type 2 diabetes in children and adolescents.
    Nadeau K, Dabelea D.
    Endocr Res; 2008 Dec; 33(1-2):35-58. PubMed ID: 19156573
    [No Abstract] [Full Text] [Related]

  • 20. Chronic hepatitis C and diabetes mellitus.
    Hwang SJ, Chen LK.
    J Chin Med Assoc; 2006 Apr; 69(4):143-5. PubMed ID: 16689193
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.